Cargando…

Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion

IMPORTANCE: Expanding Medicaid eligibility could affect prescriptions of buprenorphine with naloxone, an established treatment for opioid use disorder, and opioid pain relievers (OPRs). OBJECTIVE: To examine changes in prescriptions of buprenorphine with naloxone and OPRs after the US Affordable Car...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saloner, Brendan, Levin, Jonathan, Chang, Hsien-Yen, Jones, Christopher, Alexander, G. Caleb
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2018
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324520/ https://www.ncbi.nlm.nih.gov/pubmed/30646116 http://dx.doi.org/10.1001/jamanetworkopen.2018.1588

Ejemplares similares

Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees
por: Wen, Hefei, et al.
Publicado: (2018)

Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence
por: Mauger, Sofie, et al.
Publicado: (2014)

Changes in diabetes prescription patterns following Affordable Care Act Medicaid expansion
por: Gemelas, Jordan, et al.
Publicado: (2021)

Dental Outcomes After Medicaid Insurance Coverage Expansion Under the Affordable Care Act
por: Elani, Hawazin W., et al.
Publicado: (2021)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

Association of Medicaid Expansion Under the Patient Protection and Affordable Care Act With Use of Long-term Care
por: Van Houtven, Courtney Harold, et al.
Publicado: (2020)

Evaluation of Medicaid Expansion Under the Affordable Care Act and Contraceptive Care in US Community Health Centers
por: Darney, Blair G., et al.
Publicado: (2020)

Examination of Elective Bariatric Surgery Rates Before and After US Affordable Care Act Medicaid Expansion
por: Hanchate, Amresh D., et al.
Publicado: (2021)

The Affordable Care Act Medicaid Expansions and Personal Finance
por: Caswell, Kyle J., et al.
Publicado: (2017)

Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees
por: Hammerslag, Lindsey R., et al.
Publicado: (2023)

Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder
por: Christine, Paul J., et al.
Publicado: (2023)

Medicaid prescription limits and their implications for naloxone accessibility
por: Roberts, Andrew W., et al.
Publicado: (2021)

29. Use of Buprenorphine for Opioid Use Disorder among US Adolescents and Young Adults During the COVID-19 Pandemic
por: Alinsky, Rachel, et al.
Publicado: (2022)

Trends in Engagement With Opioid Use Disorder Treatment Among Medicaid Beneficiaries During the COVID-19 Pandemic
por: Tilhou, Alyssa Shell, et al.
Publicado: (2022)

Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail
por: Lee, Joshua D., et al.
Publicado: (2021)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

Changes in Insurance Coverage Continuity After Affordable Care Act Expansion of Medicaid Eligibility for Young Adults With Low Income in Massachusetts
por: Fung, Vicki, et al.
Publicado: (2022)

Naloxone Prescriptions Among Commercially Insured Individuals at High Risk of Opioid Overdose
por: Follman, Sarah, et al.
Publicado: (2019)

Association of Formulary Prior Authorization Policies With Buprenorphine-Naloxone Prescriptions and Hospital and Emergency Department Use Among Medicare Beneficiaries
por: Mark, Tami L., et al.
Publicado: (2020)

Opioid Drug Utilization and Cost Outcomes Associated With the Use of Buprenorphine-Naloxone in Patients With a History of Prescription Opioid Use
por: Kaur, Aman Deep, et al.
Publicado: (2008)

Treatment of Opioid Use Disorder With Buprenorphine Among US Adolescents and Young Adults During the Early COVID-19 Pandemic
por: Alinsky, Rachel H., et al.
Publicado: (2022)

The consequences of Medicaid expansion under the Affordable Care Act for police arrests
por: Simes, Jessica T., et al.
Publicado: (2022)

Association of Medicaid Expansion With Opioid Overdose Mortality in the United States
por: Kravitz-Wirtz, Nicole, et al.
Publicado: (2020)

Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States
por: Sohn, Minji, et al.
Publicado: (2019)

Early Impact of the Affordable Care Act's Medicaid Expansion on Dental Care Use
por: Nasseh, Kamyar, et al.
Publicado: (2016)

Evaluation of Cancer Care After Medicaid Expansion Under the Affordable Care Act
por: Salazar, Michelle C., et al.
Publicado: (2020)

New hypertension and diabetes diagnoses following the Affordable Care Act Medicaid expansion
por: Angier, Heather, et al.
Publicado: (2020)

Rates of Diabetes-Related Major Amputations Among Racial and Ethnic Minority Adults Following Medicaid Expansion Under the Patient Protection and Affordable Care Act
por: Tan, Tze-Woei, et al.
Publicado: (2022)

Medicaid Expansion and Prescription Trends: Opioids, Addiction Therapies, and Other Drugs
por: Cher, Benjamin A.Y., et al.
Publicado: (2019)

New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone
por: Soyka, Michael
Publicado: (2015)

Analysis of Stimulant Prescriptions and Drug-Related Poisoning Risk Among Persons Receiving Buprenorphine Treatment for Opioid Use Disorder
por: Mintz, Carrie M., et al.
Publicado: (2022)

Thematic Analysis of State Medicaid Buprenorphine Prior Authorization Requirements
por: Nguemeni Tiako, Max Jordan, et al.
Publicado: (2023)

Therapy without a prescription: buprenorphine/naloxone diversion and the therapeutic assemblage in Taiwan
por: Chen, Jia‐shin
Publicado: (2019)

Changes in Payer Mix and Physician Reimbursement After the Affordable Care Act and Medicaid Expansion
por: Jones, Christine D., et al.
Publicado: (2015)

Impact of Medicaid Expansion Under the Affordable Care Act on Receipt of Surgery for Breast Cancer
por: Elmore, Leisha C., et al.
Publicado: (2022)

Buprenorphine Use Trends Following Removal of Prior Authorization Policies for the Treatment of Opioid Use Disorder in 2 State Medicaid Programs
por: Keshwani, Shailina, et al.
Publicado: (2022)

Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial
por: Bastien, Gabriel, et al.
Publicado: (2022)

A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes
por: Lund, Ingunn O., et al.
Publicado: (2013)

Association of a Multimodal Educational Intervention for Primary Care Physicians With Prescriptions of Buprenorphine for Opioid Use Disorders
por: Clark, Brinton, et al.
Publicado: (2019)

Is Buprenorphine-Naloxone Ready for Prime Time in the Treatment of Opioid Addiction in Managed Care?
por: Curtiss, Frederic R.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_5m3c2r2j22uki3lub3sp5oavca